Blog
“Atypical psychedelic” ibogaine shows promise as a treatment for chronic disability following TBI
A landmark study published in Nature Medicine found that ibogaine, an “atypical psychedelic” derived from the root bark of an African shrub, showed highly beneficial effects on emotional well-being and cognition in a group of Special Operations Forces (SOF) veterans with chronic illness relating to their military careers and history of traumatic brain injury (TBI), primarily mild TBIs.
PTSD: MDMA-assisted therapy is more effective for PTSD than therapy alone
Research published in Nature Medicine by Mitchell and colleagues found that MDMA-assisted manualized inner-directed therapy (MDMA-AT) is a more effective treatment than manualized inner-directed therapy alone for improving moderate to severe post-traumatic stress disorder (PTSD).